Skip to main content
. 2021 Apr 30;28(1):34–43. doi: 10.1016/j.pulmoe.2021.04.001

Figure 2.

Figure 2

Summary of the potential main benefits of monoclonal antibodies for severe asthma treatment in COVID-19 Legend: AA: airways Ig: immunoglobulin; IFN: interferon; IL: interleukin; pDC: plasmacytoid dendritic cells.